Tumor cells inhibit the response and function of infiltrating immune cells by affecting the PD-1/PD-L1 signaling pathway and secreting inhibitory factors such as interleukin 2 (IL-2) to induce immune escape17. This evidence concerns the gene PDCD1 and neoplasm.